Hellström PM - Search Results

1

Switching from originator infliximab to biosimilar versus continuing on originator in inflammatory bowel disease: results from the observational Project NORTH study.

Hellström PM, Gemmen E, Ward HA, Koo H, Faccin F, Xue Z, Malmborg P. Hellström PM, et al. Scand J Gastroenterol. 2022 Dec;57(12):1435-1442. doi: 10.1080/00365521.2022.2090275. Epub 2022 Jul 14. Scand J Gastroenterol. 2022. PMID: 35833832

2

Increased luminal nitric oxide in inflammatory bowel disease as shown with a novel minimally invasive method.

Herulf M, Ljung T, Hellström PM, Weitzberg E, Lundberg JO. Herulf M, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 1998 Feb;33(2):164-9. doi: 10.1080/00365529850166897. Scand J Gastroenterol. 1998. PMID: 9517527

3

Pyoderma gangrenosum associated with crohn disease: effect of TNF-alpha blockade with infliximab.

Ljung T, Staun M, Grove O, Fausa O, Vatn MH, Hellström PM. Ljung T, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 2002 Sep;37(9):1108-10. doi: 10.1080/003655202320378338. Scand J Gastroenterol. 2002. PMID: 12374238

4

Rectal nitric oxide and fecal calprotectin in inflammatory bowel disease.

Reinders CA, Jonkers D, Janson EA, Stockbrügger RW, Stobberingh EE, Hellström PM, Lundberg JO. Reinders CA, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 2007 Oct;42(10):1151-7. doi: 10.1080/00365520701320505. Scand J Gastroenterol. 2007. PMID: 17852876

5

Blood chemistry markers for evaluation of inflammatory activity in Crohn's disease during infliximab therapy.

Lönnkvist MH, Theodorsson E, Holst M, Ljung T, Hellström PM. Lönnkvist MH, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 2011 Apr;46(4):420-7. doi: 10.3109/00365521.2010.539253. Epub 2010 Nov 30. Scand J Gastroenterol. 2011. PMID: 21114432

6

Nitric oxide pathway-related gene alterations in inflammatory bowel disease.

Gillberg L, Varsanyi M, Sjöström M, Lördal M, Lindholm J, Hellström PM. Gillberg L, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 2012 Nov;47(11):1283-97. doi: 10.3109/00365521.2012.706830. Epub 2012 Aug 20. Scand J Gastroenterol. 2012. PMID: 22900953

7

Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy.

Engström J, Lönnkvist M, Befrits R, Ljung T, Diaz-Tartera H, Holst M, Hellström PM. Engström J, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 2019 Sep;54(9):1081-1088. doi: 10.1080/00365521.2019.1660402. Epub 2019 Sep 9. Scand J Gastroenterol. 2019. PMID: 31499013

8

Gastroparesis versus dyspepsia by intragastric meal distribution: new diagnostics and definitions ahead.

Grybäck P, Jacobsson H, Neuger L, Hellström PM. Grybäck P, et al. Among authors: hellstrom pm. Scand J Gastroenterol. 2020 Feb;55(2):251-255. doi: 10.1080/00365521.2019.1710244. Epub 2020 Jan 12. Scand J Gastroenterol. 2020. PMID: 31928242

9

Occurrence, release, and effects of multiple tachykinins in cat colonic tissues and nerves.

Hellström PM, Söder O, Theodorsson E. Hellström PM, et al. Gastroenterology. 1991 Feb;100(2):431-40. doi: 10.1016/0016-5085(91)90213-5. Gastroenterology. 1991. PMID: 1702076

10

Neuropeptide Y, peptide YY, and sympathetic control of rectal tone and anal canal pressure in the cat.

Hellström PM, Lundberg JM, Hökfelt T, Goldstein M. Hellström PM, et al. Scand J Gastroenterol. 1989 Mar;24(2):231-43. doi: 10.3109/00365528909093041. Scand J Gastroenterol. 1989. PMID: 2564694

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

338 results

Search Page

Filters